Suchergebnisse - "Shaw, David"

PubPharm (25)

1

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

enthalten in: Journal of hepatology | 2021

von Matthews, G. | Bhagani, S. | Van der Valk, M. | +67

2

COVID-19 in Australia : our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phase

enthalten in: Internal medicine journal | 2021

von Shaban, R. | Li, C. | O'Sullivan, M. | +38

3

Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection

enthalten in: Hepatology (Baltimore, Md.) | 2020

von Martinello, M. | Orkin, C. | Cooke, G. | +11

4

Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis

enthalten in: Journal of hepatology | 2019

von Borgia, S. | Dearden, J. | Yoshida, E. | +26

CommentIn: J Hepatol. 2021 Oct;75(4):1006-1007. - PMID 34051333

5

Fixation of periprosthetic or osteoporotic distal femoral fractures with locking plates : a pilot randomised controlled trial

enthalten in: International orthopaedics | 2019

von Kanakaris, N. | Obakponovwe, O. | Krkovic, M. | +5

6

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use : The SIMPLIFY study

enthalten in: The International journal on drug policy | 2018

von Cunningham, E. | Amin, J. | Feld, J. | +26

7

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Poordad, F. | Pol, S. | Asatryan, A. | +17

8

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY) : an open-label, single-arm, phase 4, multicentre trial

enthalten in: The lancet. Gastroenterology & hepatology | 2018

von Grebely, J. | Dalgard, O. | Conway, B. | +29

CommentIn: Lancet Gastroenterol Hepatol. 2018 Mar;3(3):142-143. - PMID 29310927

9

Is failure to raise concerns about misconduct a breach of integrity? Researchers' reflections on reporting misconduct

enthalten in: Accountability in research | 2018

von Satalkar, P. | Shaw, D.

10

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection : The ACTIVATE study

enthalten in: The International journal on drug policy | 2017

von Grebely, J. | Dalgard, O. | Cunningham, E. | +21